TSA Policy Allows Medical Cannabis Through Airport Security Amidst State Law Nuances and Traveler Confusion

May 23, 2026

The Transportation Security Administration (TSA) has adjusted its policy regarding medical cannabis travel, now permitting passengers to carry medical marijuana through airport security checkpoints under specific conditions. This shift, reported by ClickOrlando, impacts travelers at facilities such as Orlando International Airport, where many passengers expressed ongoing confusion about the updated guidelines.

While the TSA’s revised stance represents a departure from previous federal restrictions on cannabis in security lines, authorities emphasize that state and local laws remain applicable. This creates a complex regulatory environment for individuals seeking to travel with medical cannabis.

TSA’s Evolving Stance on Medical Cannabis

The TSA’s policy adjustment allows for medical cannabis travel, a change that follows broader federal discussions regarding cannabis classification. According to the May 22, 2026, ClickOrlando report, the Trump administration had moved to reclassify marijuana from a Schedule I drug to a less restrictive Schedule III drug in April, preceding this policy update. This federal reclassification, as previously covered by Hemp Gazette, has been a significant factor influencing regulatory bodies.

TSA officers are primarily focused on identifying security threats to passengers and aircraft, rather than actively searching for marijuana or other illicit drugs. This operational focus underpins the updated policy, though it does not negate the legal status of cannabis under various jurisdictions.

Navigating State and Local Cannabis Laws

Despite the federal policy shift, the legality of medical cannabis travel is heavily contingent on state and local regulations. In Florida, for instance, possession of marijuana is only legal for patients holding a valid medical marijuana license. The Orlando Police Department has stated that its officers, if called to a security checkpoint, will evaluate circumstances and enforce applicable laws accordingly.

For individuals without a medical marijuana license in the City of Orlando, possession of less than 20 grams of marijuana can result in a US$100 fine. This highlights the jurisdictional complexities that travelers encounter, where federal allowances may not align with local enforcement.

  • TSA officers do not specifically search for marijuana.
  • State and local laws regarding cannabis possession still apply.
  • Orlando Police Department will enforce local laws if called to a security incident.
  • Unlicensed possession in Orlando can incur a US$100 fine for quantities under 20 grams.

Industry and Patient Implications

The reported confusion among travelers at Orlando International Airport underscores the need for clearer communication regarding medical cannabis travel policies. Many passengers interviewed by News 6 expressed unawareness of the policy change, indicating a gap in public understanding despite the regulatory updates.

For the medical cannabis industry, these policy developments present both opportunities and challenges. While increased allowance for patient travel could expand access, the persistent ambiguity surrounding verification of medical licenses and the interplay of federal, state, and local laws create operational hurdles. Stakeholders, including patients, prescribers, and licensed producers, must remain informed of these evolving regulations to ensure compliance and facilitate patient access.


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.